October 28, 2016 1 min read 2 Comments

On International Women's Day, we are excited to announce Maternova’s newest addition to our groundbreaking obstetric and neonatal health products: the CRADLE.   The CRADLE Vital Signs Alert is the first device specifically designed to measure heart rate and blood pressure for pregnant women. There have been extensive trials and field testing that have proven both the effectiveness of the VSA, and the ease of use in low-resource settings. It has also been approved by the World Health Organization and was recognized as one of thirty high impact innovations in global health by a PATH-led award.

Needless to say, we are thrilled to be the distributor of Vital Signs Alert and begin spreading this high-impact innovation. Three of the most common causes of death during pregnancy are severe bleeding, infection, and blood pressure disorders, all of which are correlated with abnormal vital signs. More specifically, pre-eclampsia and eclampsia cause 10-15% of all maternal deaths, and high blood pressure is the most telling symptom. Pre-eclampsia can be managed with medication until the baby is delivered, after which symptoms usually resolve.

However, preeclampsia cannot be managed if it is not detected. Using the VSA, it is easy to see if a pregnant woman has abnormal vital signs and requires further attention. A unique feature facilitating the ease of use is the traffic signal warnings (red, yellow and green lights to indicate risk level), so even if the device is not used by a medically trained health worker, it will be easy to tell if a pregnant woman is at risk. 

2 Responses

Silvia Chavez
Silvia Chavez

June 03, 2020

would like to have a quotation for 100 CRADLE VSA BLOOD PRESSURE MONITOR

thank you 001-438-887-4571

Owen Bero
Owen Bero

November 08, 2016

I would like to have a quotation for 100 CRADLE VSA BLOOD PRESSURE MONITOR

Leave a comment

Comments will be approved before showing up.

Also in The Maternova blog

Anemia in Pregnancy:  A Public Health Problem
Anemia in Pregnancy: A Public Health Problem

June 18, 2022 3 min read

Identification of anemia in pregnant women is important, since it is an important cause of multiple complications during pregnancy (preterm delivery, low birth weight and perinatal death), so it is recommended to all pregnant women, in the first prenatal visit and at 28 weeks of gestation, the measurement of serum concentrations of hemoglobin and hematocrit as a screening test for anemia.
Read More
Can preeclampsia be prevented?
Can preeclampsia be prevented?

June 01, 2022 3 min read

Prenatal assessment seeks to identify, through clinical history, sociodemographic characteristics, mean blood pressure, Doppler of the uterine arteries and biochemical markers such as pregnancy-associated plasma protein A (PAPP-A) and placental growth factor (PlGF), those women who are at high risk of developing preeclampsia in order to take appropriate measures. that can help reduce that risk.
Read More
The team going out to the Bilatum village,  Borno State, Nigeria to reach pregnant women
How I Survived Eclampsia through an Emergency Visit After a Birth in Borno State, Nigeria

January 15, 2022 2 min read

Read More